Sign in →

Test Code WAGDR Alpha Globin Cluster Locus Deletion/Duplication, Blood


Ordering Guidance


Sequence variants, other than the alpha T-Saudi and hemoglobin Constant Spring alterations, are not detected by this assay. For detection of single point and other nondeletion variants, order WASEQ / Alpha Globin Gene Sequencing, Varies, if clinically indicated.



Shipping Instructions


 



Specimen Required


Patient Preparation: A previous bone marrow transplant from an allogeneic donor will interfere with testing. For instructions for testing patients who have received a bone marrow transplant, call 800-533-1710.

 

Specimen Type: Whole blood

Container/Tube:

Preferred: Lavender top (EDTA)

Acceptable: Yellow top (ACD)

Specimen Volume: 3 mL

Collection Instructions:

1. Invert several times to mix blood.

2. Send whole blood specimen in original tube. Do not aliquot.


Forms

1. New York Clients-Informed consent is required. Document on the request form or electronic order that a copy is on file. The following documents are available in Special Instructions:

-Informed Consent for Genetic Testing (T576)

-Informed Consent for Genetic Testing-Spanish (T826)

2. Molecular Genetics: Congenital Inherited Diseases Patient Information (T521)

Useful For

Diagnosis of alpha-thalassemia

 

Carrier screening for individuals from high-risk populations for alpha-thalassemia

 

This test is not useful for diagnosis or confirmation of beta-thalassemia or hemoglobinopathies.

Method Name

Dosage Analysis by Polymerase Chain Reaction (PCR)/Quantitative Polymerase Chain Reaction (qPCR)/Multiplex Ligation-Dependent Probe Amplification (MLPA)

Reporting Name

Alpha Globin Clustr Locus Del/Dup,B

Specimen Type

Varies

Specimen Minimum Volume

Blood: 1 mL

Specimen Stability Information

Specimen Type Temperature Time
Varies Varies

Reference Values

An interpretive report will be provided.

Interpretation

The interpretive report includes an overview of the findings as well as the associated clinical significance.

Clinical Reference

1. Harteveld CL, Voskamp A, Phylipsen M, et al. Nine unknown rearrangements in 16p13.3 and 11p15.4 causing alpha- and beta-thalassaemia characterized by high resolution multiplex ligation-dependent probe amplification. J Med Genet. 2005;42(12):922-931. doi:10.1136/jmg.2005.033597

2. Harteveld CL, Higgs DR. Alpha-thalassemia. Orphanet J Rare Dis. 2010;5:13. doi:10.1186/1750-1172-5-13

3. Bunn HF, Forget BG. Hemoglobin: Molecular, Genetic and Clinical Aspects. 2nd ed. WB Saunders Company; 1986

4. Weatherall DJ, Higgs DR, Clegg JB, Hill AS, Nicholls R. Heterogeneity and origins of the alpha-thalassemias. Birth Defects Origi Artic Ser. 1987;23(5A):3-14

5. Musallam KM, Cappellini DM, Coates TD, et al. ?lpha-thalassemia: A practical overview. Blood Rev. 2024;64:101165. doi.10.1016/j.blre.2023.101165

Day(s) Performed

Varies

Report Available

9 to 13 days

Performing Laboratory

Mayo Clinic Laboratories in Rochester

Test Classification

This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.

CPT Code Information

81269

LOINC Code Information

Test ID Test Order Name Order LOINC Value
WAGDR Alpha Globin Clustr Locus Del/Dup,B 90040-7

 

Result ID Test Result Name Result LOINC Value
621362 Result Summary 50397-9
621363 Result 82939-0
621364 Interpretation 69047-9
621365 Additional Information 48767-8
621366 Specimen 31208-2
621367 Source 31208-2
621368 Method 85069-3
621804 Disclaimer 62364-5
621369 Released By 18771-6